Tris Pharma Issues Voluntary Nationwide Recall of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations...
The Rhode Island Department of Health is alerting consumers that Tris Pharma, Inc. has voluntarily recalled three lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAI…
